{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:38:37Z","timestamp":1762864717078},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.diagmicrobio.2003.09.009","type":"journal-article","created":{"date-parts":[[2004,3,2]],"date-time":"2004-03-02T19:36:36Z","timestamp":1078256196000},"page":"101-105","source":"Crossref","is-referenced-by-count":73,"title":["In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents"],"prefix":"10.1016","volume":"48","author":[{"given":"M.A","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J","family":"Diekema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A","family":"Messer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Boyken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.N","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/43.2.295","article-title":"In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp","volume":"43","author":"Barchiesi","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB2","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/JCM.38.9.3457-3459.2000","article-title":"Quality control limits for broth microdilution susceptibility tests of ten antifungal agents","volume":"38","author":"Barry","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/JCM.36.3.792-795.1998","article-title":"A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies","volume":"36","author":"D'Antonio","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/0003-4819-102-1-67","article-title":"Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii","volume":"102","author":"Dick","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB5","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1128\/AAC.43.9.2236","article-title":"In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida in North America and Latin America","volume":"43","author":"Diekema","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/18.1.77","article-title":"Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit","volume":"18","author":"Dube","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.36.1.198-202.1998","article-title":"In vitro activity of the new triazole voriconazole (UK-109, 496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1010954803886","article-title":"In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods","volume":"150","author":"Espinel-Ingroff","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/AAC.42.4.993","article-title":"In vitro activity of a new oral triazole, BMS-207147 (ER-30346)","volume":"42","author":"Fung-Tomc","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB10","first-page":"22","volume":"839","author":"Grasela","year":"2000"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/AAC.40.10.2237","article-title":"In vitro and in vivo activities of ER-30346, a novel oral triazole with a broad antifungal spectrum","volume":"40","author":"Hata","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/CMR.8.4.462","article-title":"New and emerging yeast pathogens","volume":"18","author":"Hazen","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1128\/JCM.37.4.1035-1044.1999","article-title":"Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis","volume":"37","author":"Joly","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB14","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-second edition M27-A2","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0732-8893(98)00120-5","article-title":"Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B","volume":"32","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB16","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","article-title":"International surveillance of bloodstream infections due to Candida species","volume":"39","author":"Pfaller","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/AAC.46.6.1723-1727.2002","article-title":"In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6, 970 clinical isolates of Candida spp","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB18","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/JCM.40.10.3551-3557.2002","article-title":"Role of sentinel surveillance of candidemia","volume":"40","author":"Pfaller","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/JCM.41.1.78-83.2003","article-title":"In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood","volume":"41","author":"Pfaller","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB21","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/AAC.39.11.2520","article-title":"Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing","volume":"39","author":"Wanger","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB22","series-title":"Candida, Cryptococcus, and other yeasts of medical importance","first-page":"1184","author":"Warren","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2003.09.009_BIB23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T09:26:21Z","timestamp":1585646781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889303002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0732889303002104"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2003.09.009","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}